Surgimab
  • Science
    • Technology
    • Pipeline
    • Clinical trials
    • Publications
  • About SurgiMab
    • History
    • Our team
    • Partners
  • News
  • Contact
Select Page
SurgiMab is part of the 15 laureates of the 2014 Netva competition

SurgiMab is part of the 15 laureates of the 2014 Netva competition

by kwal1 | Jul 18, 2014 | News

SurgiMab is happy to announce that it is part of the 15 laureates – selected among 87 young innovative companies – of the NETVA program. NETVA (NEw Technology Venture Accelerator) is a unique program of preparation and exposure to high-tech U.S. markets for...

8th CHIP meeting in Montpellier

by kwal1 | May 18, 2014 | News

SurgiMab will attend the 8th “CHIP / HIPEC meeting” that will take place in Montpellier on May 23rd, 2014.
8th annual meeting of the European Society for Molecular Imaging – ESMI

8th annual meeting of the European Society for Molecular Imaging – ESMI

by kwal1 | May 18, 2013 | News

On the occasion of the 8th annual meeting of the European Society for Molecular Imaging in Torino (26 to 28 May, 2013) Françoise Cailler, CEO of SurgiMab, will present the company’s R&D programs during the “Intra-Operative Imaging” session,...

In the press : “SurgiMab to sign a deal with a French CMO…”

by kwal1 | Jun 5, 2012 | News

On the occasion of the Grenoble EuroMedtech meeting that took place between May 31st and June 1st 2012, Françoise Cailler, SurgiMab’s president, answered BioPharmInsight’s questions (the Financial Times group). She describes the next steps for SurgiMab in...
SurgiMab is awarded the “Innovative Enterprise” certification from Oseo

SurgiMab is awarded the “Innovative Enterprise” certification from Oseo

by kwal1 | Apr 18, 2012 | News

OSEO, a public institution promoting the innovation and growth of SMEs, awarded SurgiMab the status of Innovative Enterprise and its FCPI certification (Mutual Funds for Innovation) in April.

SurgiMab receives 1 Million € from its investors to bring its first product to the clinic

by kwal1 | Feb 9, 2012 | News

Convinced by the development program that was launched by the young start-up and by the dynamic team that was installed, and following the obtention of a 450 000 € aid from Oseo / Languedoc-Roussillon Region, SurgiMab’s investors decided to consolidate their...
« Older Entries
Next Entries »

Articles récents

  • SurgiMab Honored with the “Tech for Future 2025” Award in Healthcare by La Tribune, France – April 2, 2025
  • Françoise Cailler, CEO of surgiMab, will attend the WMIC2024 Congress in Montreal
  • SurgiMab will sponsor the next edition of the International Symposium on Fluorescence Guided Surgery, 2-3 Nov 2023 in Amsterdam
  • SurgiMab will participate to the conference “Optics in the Life Sciences” during the Optica Biophotonics Congress in Vancouver April 23 – 27, 2023
  • SurgiMab co-sponsors the Molecular-Guided Surgery meeting that will take place during the SPIE Photonics West conference in San Francisco on Jan 22-23, 2022.

Commentaires récents

No comments to show.

Contact

Francoise Cailler: +33 467 798 381
Michel Barbelanne: +33 467 798 382

Legal

Legals, privacy & cookies

  • Science
    • Technology
    • Pipeline
    • Clinical trials
    • Publications
  • About SurgiMab
    • History
    • Our team
    • Partners
  • News
  • Contact